Laser Treatment for Vascular & Pigmented Lesions
Non-surgical, quick and effective
Nearly 100% of all people have one or more pigmented lesion. Some are caused by sun exposure, others by aging. Still others are congenital. Regardless of the cause, pigmented lesions are simply spots on the skin where there is a higher concentration of melanin. Some lesions are flat; others are raised.
In most cases, pigmented lesions are merely a cosmetic concern, but in some cases, they can be an early sign of skin cancer.
Technology in use
AFT is the next generation of intense pulsed light (IPL). It takes formerly unused short-wavelength light and converts it into part of the usable spectrum through a special filtering system. It increases emission and penetration, for safer and more effective treatments.
AFT also delivers Equally Distributed Fluence, which means that every pulse has uniform energy density across the entire output face. This fluence ensures repeatable results and remarkable safety. AFT yields a more efficient system for ideal clinical improvements, less discomfort and minimal skin damage.
The Technology of Choice for Treating Vascular Lesions
Since Alma introduced its Dye-VL module, industry leaders have proclaimed it the technology of choice when treating vascular lesions.
The Dye-VL module, exclusive to Alma’s flagship Harmony XL PRO, gives providers a way of utilizing Dye-VL technology with the safety, reliability and affordability of pulsed light.
-Full Face or Hands or Neck $400/ Session
-Lower arms/ Upper Arms or Chest $550/ Session
-Upper or Lower Back, or Full Arms $900/ Session
On average it takes 3-5 sessions of treatment for an ideal result
Prices are subject to change without notification
We are only able to provide the treatment for Skin Type I-IV by FDA protocol
Treatment uses include:
Port wine stains
AFT™ technology converts unused light into the usable spectrum, increasing emission and penetration into the treatment area and allowing for lower fluence to be used to achieve the desired outcome.
With lower energy required to achieve results, the chances of unwanted side effects are minimized. This gives providers and patients an unparalleled level of safety.
The Dye-VL utilizes a narrowband 500-600nm wavelength. The narrowband gives providers the precision required to target only the melanin in the lesion or blood vessel.
The combined innovations help providers achieve superior results with minimal risk to surrounding tissue.
Providers can also feel more comfortable treating areas of the skin that are hard to reach or problematic for previous technologies.
Each treatment begins with the easy-to-use, color touch screen on the Harmony XL PRO. The interface features a grid-based method of programming for enhanced results and speedier procedures.